Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
1.58Price to Book
VS
Market
Sector
Industry
History
$ 5.45Close
$ 2.42 - $ 5.73 52-Week Range
Ticker Information
Ticker
PBYICompany Name
PUMA BIOTECHNOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQPUMA BIOTECHNOLOGY INC - Price to Book Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
PBYI - P/B Historical data
| Date | Shareholders Equity | Market Capitalization | Price to Book |
|---|---|---|---|
| 6/30/2025 | $ 104.72M | $ 165.72M | 1.58 |
| 3/31/2025 | $ 97.11M | $ 152.39M | 1.57 |
| 12/31/2024 | $ 92.13M | $ 148.34M | 1.61 |
| 9/30/2024 | $ 71.09M | $ 148.74M | 2.09 |
| 6/30/2024 | $ 48.51M | $ 171.66M | 3.54 |
| 3/31/2024 | $ 50.98M | $ 239.26M | 4.69 |
| 12/31/2023 | $ 53.44M | $ 299.85M | 5.61 |
| 9/30/2023 | $ 38.74M | $ 118.45M | 3.06 |
| 6/30/2023 | $ 30.4M | $ 167.23M | 5.5 |
| 3/31/2023 | $ 25.85M | $ 121.91M | 4.72 |
Key Performance Insights, Last 5 Years
- PUMA BIOTECHNOLOGY INC's latest trailing twelve months (TTM) P/B stands at 0.
- Over the past 5 years, PUMA BIOTECHNOLOGY INC's average P/B has been 6.38.
- The median P/B for PUMA BIOTECHNOLOGY INC during this period was 4.7
- PUMA BIOTECHNOLOGY INC reached its highest P/B over the past 5 years at 23.77.
- The lowest P/B recorded by PUMA BIOTECHNOLOGY INC in the same timeframe 1.57
PUMA BIOTECHNOLOGY INC's P/B vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/B Benchmarks
Similar metrics to P/B:
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
Definition of Price to Book
[Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].Market Cap / Equity
(=) P/B P/B for PUMA BIOTECHNOLOGY INC is calculated as follows: Market Cap [ $ 336.79M ] / Equity [ $ -453K ]
(=) P/B [ 0 ] PBYI - Price to Book, Last 5 years
1.57
Minimum
Mar 31, 2025
23.77
Maximum
Mar 31, 2021
6.38
Average
4.7
Median
P/B Benchmark AnalysisMarket
The chart above depicts the distribution of P/B for companies in the Total Stock Market. The average P/B of the companies is 2.29 with a standard deviation of 1.81.
The following table provides additional summary stats:
P/B in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | 0 |
| max | 8.04 |
| average | 2.29 |
| median | 1.63 |
| std | 1.81 |